Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-005602-31Phase 4Active
Phase 4, randomised trial of clobetasol in atopic dermatitis (AD) (2 arms), sponsored by Academic Medical Center. Primary endpoint: Primary efficacy of excimer laser in prurigo form of atopic dermatitis. Started Oct 2006; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-005602-31.